Thomas Candler Gilliland, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dyslipidemias | 1 | 2024 | 873 | 0.540 |
Why?
|
Coronary Artery Disease | 3 | 2024 | 6568 | 0.500 |
Why?
|
Hypopituitarism | 1 | 2016 | 253 | 0.460 |
Why?
|
Lipoprotein(a) | 3 | 2024 | 489 | 0.450 |
Why?
|
Human Growth Hormone | 1 | 2016 | 651 | 0.380 |
Why?
|
Phospholipids | 2 | 2024 | 787 | 0.340 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12795 | 0.320 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2227 | 0.290 |
Why?
|
Liver Transplantation | 2 | 2016 | 2401 | 0.280 |
Why?
|
Venous Thromboembolism | 3 | 2024 | 1883 | 0.250 |
Why?
|
Apolipoprotein B-100 | 1 | 2024 | 157 | 0.220 |
Why?
|
Apoprotein(a) | 1 | 2023 | 17 | 0.220 |
Why?
|
Apolipoproteins A | 1 | 2023 | 96 | 0.210 |
Why?
|
Apolipoproteins B | 1 | 2023 | 386 | 0.190 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15662 | 0.170 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1040 | 0.150 |
Why?
|
Blood Vessel Prosthesis | 2 | 2015 | 956 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.140 |
Why?
|
Coronary Care Units | 1 | 2018 | 235 | 0.140 |
Why?
|
Patient Admission | 2 | 2019 | 1365 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1674 | 0.120 |
Why?
|
Dioxoles | 1 | 2015 | 96 | 0.120 |
Why?
|
Foam Cells | 1 | 2014 | 68 | 0.110 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 304 | 0.110 |
Why?
|
Lipids | 1 | 2024 | 3343 | 0.110 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 252 | 0.100 |
Why?
|
Peripheral Arterial Disease | 1 | 2024 | 1304 | 0.100 |
Why?
|
E2F1 Transcription Factor | 1 | 2012 | 182 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2022 | 1605 | 0.100 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1104 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2298 | 0.080 |
Why?
|
Fibrosis | 1 | 2016 | 2080 | 0.080 |
Why?
|
Benzamides | 1 | 2015 | 1379 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2784 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2957 | 0.080 |
Why?
|
Deafness | 1 | 2012 | 460 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16726 | 0.060 |
Why?
|
Critical Illness | 1 | 2018 | 2756 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2819 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18065 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2015 | 1893 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8509 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3415 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3711 | 0.050 |
Why?
|
Humans | 15 | 2024 | 768166 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5520 | 0.050 |
Why?
|
Aged | 6 | 2024 | 171504 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 223492 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4937 | 0.040 |
Why?
|
Male | 8 | 2024 | 364719 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2013 | 2333 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2014 | 3433 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9523 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4362 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 788 | 0.030 |
Why?
|
Female | 7 | 2024 | 397192 | 0.030 |
Why?
|
Shock | 1 | 2018 | 316 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2024 | 1162 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1422 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2012 | 4712 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11879 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2227 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2131 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65371 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2015 | 408 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18349 | 0.030 |
Why?
|
Adult | 2 | 2024 | 223646 | 0.020 |
Why?
|
Ganglion Cysts | 1 | 2012 | 27 | 0.020 |
Why?
|
RNA, Ribosomal | 1 | 2012 | 227 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 74944 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 644 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 24315 | 0.020 |
Why?
|
Hepatectomy | 1 | 2013 | 588 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2018 | 1240 | 0.020 |
Why?
|
Health | 1 | 2012 | 398 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1516 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 89169 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2566 | 0.020 |
Why?
|
Ear, Inner | 1 | 2012 | 426 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1885 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3251 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9374 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2012 | 872 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5926 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 979 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54926 | 0.020 |
Why?
|
Critical Care | 1 | 2018 | 2715 | 0.020 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2194 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3288 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1369 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2018 | 3800 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2018 | 5349 | 0.010 |
Why?
|
Forecasting | 1 | 2013 | 2945 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5777 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2149 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59629 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10590 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3857 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 16045 | 0.010 |
Why?
|
Mice | 3 | 2015 | 82029 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8375 | 0.010 |
Why?
|
Animals | 4 | 2015 | 169246 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39348 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9561 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41754 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14488 | 0.010 |
Why?
|
Mitochondria | 1 | 2012 | 3681 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40218 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22379 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8054 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9615 | 0.010 |
Why?
|
Neurons | 1 | 2012 | 9514 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12168 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81762 | 0.010 |
Why?
|
United States | 1 | 2018 | 73039 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23645 | 0.000 |
Why?
|
Mutation | 1 | 2012 | 30238 | 0.000 |
Why?
|